(1)
The Impact of CYP2C9 Rs1057910 and rs1799853 Polymorphism on the Effectiveness of Glibenclamide in T2DM Iraqi Patients. Genetics and Mol. Res. 2026, 25 (1), 1-25. https://doi.org/10.4238/1fvw5h08.